Den europeiske union -
norsk -
EMA (European Medicines Agency)
inlyta
pfizer europe ma eeig - axitinib - karsinom, nyrecelle - protein kinase hemmere - inlyta is indicated for the treatment of adult patients with advanced renal cell carcinoma (rcc) after failure of prior treatment with sunitinib or a cytokine.
Norge -
norsk -
Statens legemiddelverk
inlyta 7 mg
orifarm as - aksitinib - tablett, filmdrasjert - 7 mg